Clinical
Study - Topical Camphor/Glucosamine/Chondroitin
Sulfate Effective For Osteoarthritis Knee Pain
 |
Recently
released clinical studies confirm that using the appropriate
combination of ingredients working synergistically provided
nearly instantaneous relief for those who suffer from
chronic osteoarthritis pain.*
* The use of Glucosamine
and camphor applied topically was studied at the Department
of Complementary Medicine, RMIT University, and the
Center for Complementary Medicine, Monash University
in Melbourne, Australia.
Topical Camphor/Glucosamine/Chondroitin
Sulfate Effective For Osteoarthritis Knee Pain
Quoted in Part:
NEW YORK, NY -- March 3, 2003 -- Results of a clinical
study published in the March 2003 Journal of Rheumatology
show long term benefits of topical application of a
preparation containing camphor, Glucosamine
and chondroitin sulfate. The study, "A Randomized, Double-Blind,
Placebo-Controlled Trial of a Topical Cream Containing
Glucosamine
Sulfate, Chondroitin Sulfate and Camphor for Osteoarthritis
of the Knee," shows continuous reduction of pain due
to osteoarthritis of the knee, with clinically significant
results within four weeks. According to the study's
principal investigator, the study also suggests that
topical application of these agents... is an effective
route of administration.
|
Under the auspices of the Department of Complementary Medicine,
RMIT University, and the Centre for Complementary Medicine,
Monash University, both in Melbourne, Australia, a single
centered, randomized, double-blind, placebo-controlled trial
was performed with 63 subjects chosen from the community after
assessment for eligibility. Key to the assessment criteria
was a diagnosis of osteoarthritis of the knee based on the
American College of Rheumatology definition, which includes
knee pain most days during the prior month, as well as morning
stiffness of the knee for 30 minutes or less. Patients were
randomly assigned to use either a topical preparation containing
camphor, Glucosamine,
and chondroitin sulfate, or a placebo, for eight weeks. The
two treatment groups were similar with respect to demographic
composition and illness history.
The active preparation was a water-soluble cream containing
Glucosamine
sulfate, chondroitin sulfate and shark cartilage of which
10 to 30 percent is chondroitin sulfate, camphor.... The placebo
preparation was a simple cosmetic cream that used conventional
skin emollients, petrolatum and mineral oil, and conventional
emulsifiers; stearic acid and glycerol stearate, rather than
the proprietary technology.
The primary outcome measure was an assessment of subjective
pain using a Visual Analogue Scale (VAS). Secondary outcome
measures included measures of pain, stiffness and physical
function using the Western Ontario and the McMaster Universities
Osteoarthritis Index (WOMAC) and quality of life using the
SF-36 questionnaire.
The study showed a significant difference between the two
groups existed after the first day of use of creams. Nearly
all of the patients... obtained immediate pain relief. Additionally,
the results showed there was a greater mean sustained reduction
in pain at both four weeks and eight weeks for the JointFlex
group compared to the placebo group. A majority... experienced
gradually and continually improving pain relief over the eight
weeks. A surprising result was that with continued use, one-third
of the... group had their chronic osteoarthritis pain completely
or nearly completely eliminated within eight weeks or less.
According to Marc Cohen, MD, PhD, Department of Complementary
Medicine, Faculty of Life Sciences, RMIT University, and principal
investigator of this study, "The observed gradual and continual
improvement in pain scores is likely to be due to the Glucosamine
and chondroitin content and this is consistent with previous
studies."
Oral administration of Glucosamine
and chondroitin sulfate have been consistently shown in previous
studies to relieve the pain and joint stiffness associated
with osteoarthritis and long-term consumption of Glucosamine
may reduce the radiographic progression of osteoarthritis
of the knee.
Says Dr. Cohen, "Our results clearly show that the proprietary
system in this product effectively targets osteoarthritic
knee pain and provides immediate pain relief along with long
term improvement of pain with continued use." Dr. Cohen adds,
"The study shows promise, regardless of mode of action, for
those osteoarthritis patients who have not had success with
oral Glucosamine/chondroitin,
or, who prefer to apply a topical preparation over taking
numerous pills several times a day." The Journal of Rheumatology
is available online at http://www.jrheum.com.
SOURCE: SmartScience Laboratories, Inc.
All contents Copyright (c) 1995- Doctor's Guide Publishing
Limited. All rights reserved. |